Chylomicron
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Chylomicron | |
|
Articles | |
|---|---|
|
Most recent articles on Chylomicron Most cited articles on Chylomicron | |
|
Media | |
|
Powerpoint slides on Chylomicron | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Chylomicron at Clinical Trials.gov Clinical Trials on Chylomicron at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Chylomicron
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Chylomicron Discussion groups on Chylomicron Patient Handouts on Chylomicron Directions to Hospitals Treating Chylomicron Risk calculators and risk factors for Chylomicron
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Chylomicron | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Chylomicrons are large lipoprotein particles (having a diameter of 75 to 1,200nm) that are created by the absorptive cells of the small intestine.The chylomicrons are released by exocytosis from enterocytes into lacteals, lymphatic vessels originating in the villi of the small intestine, and are then secreted into the bloodstream at the thoracic duct's connection with the left subclavian vein. Chylomicrons transport exogenous lipids to liver, adipose, cardiac and skeletal muscle tissue where they are broken down by lipoprotein lipase into very low density lipoproteins (VLDLs).
Contents when released
Nascent chylomicrons are primarily composed of triglycerides (85%) and contain some cholesterol and cholesteryl esters. The main apolipoprotein component is apolipoprotein B-48 (APOB48).
Changes during circulation
While circulating in lymph and blood, chylomicron exchanges components with High Density Lipoproteins (HDL). The HDL donates apolipoprotein C-II (APOC2) and apolipoprotein E (APOE) to the nascent chylomicron and thus matures it into a "chylomicron." APOC2 is the cofactor for lipoprotein lipase (LPL) activity. Once triglyceride stores are distributed, the chylomicron returns APOC2 (but keeps APOE) back to the HDL and thus becomes a chylomicron remnant. APOB48 and APOE are important to identify the chylomicron remnant in the liver for endocytosis and breakdown.
Lipids: lipoprotein metabolism | |
|---|---|
| General | Chylomicron - HDL - LDL - IDL - VLDL - Lp(a) |
| Apolipoproteins | APOA (1, 2, 5) - APOB - APOC (1, 2, 3, 4) - APOD - APOE - APOH |
| Other | Lipoprotein lipase - HDL (Cholesterylester transfer proteinAcetyl-CoA C-acyltransferase, LCAT) - LDL receptor - Microsomal triglyceride transfer protein - ABCA1 - Lecithin-cholesterol acyltransferase |
| see also disorders | |
it:Chilomicroni nl:Chylomicronfi:Kylomikroni sv:Kylomikron
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

